FDA Convening Panel to Reconsider Safety of Essure Birth Control System
On September 24, 2015, the Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee of the Food and Drug Administration (FDA) will meet to discuss the risks and benefits of Bayer HealthCare's Essure birth control system. The panel will seek expert scientific and clinical opinion on the risks and benefits … [Read more...] about FDA Convening Panel to Reconsider Safety of Essure Birth Control System
In Light of Patient Complaints, FDA to Reconsider Safety of Essure Permanent Birth Control
The U.S. Food and Drug Administration (FDA) will be re-evaluating the safety of Essure following complaints from patients who say the permanent birth control device caused painful complications. Currently, it is the only approved permanent nonsurgical form of contraception on the market. NPR reports that the agency’s Obstetrics and … [Read more...] about In Light of Patient Complaints, FDA to Reconsider Safety of Essure Permanent Birth Control
